Document Detail


Chronic left ventricular failure in the community: Prevalence, prognosis, and predictors of the complete clinical recovery with return of cardiac size and function to normal in patients undergoing optimal therapy.
MedLine Citation:
PMID:  15190536     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Chronic heart failure (CHF) is a progressive process requiring complex therapeutic interventions. Recently, several trials documented the clinical improvement and regression of left ventricular (LV) remodeling and function in patients on optimized CHF treatment. Furthermore, some authors reported isolated cases of patients who apparently "healed" from CHF. The aim of the present study was to characterize the phenomenon of the normalization in clinical status and LV size and function in CHF patients. METHODS AND RESULTS: We monitored the clinical and echocardiographic parameters of a large cohort of patients with CHF and LV ejection fraction <40% every 6 months for a mean period of 17 +/- 9 months. Twenty of 110 study patients (18%) normalized clinical status and LV size and ejection fraction at any time (mean time 13 +/- 6 months) during the follow up. Such condition, however, was subsequently lost in 11 patients. The normalization was predicted by the nonischemic etiology of CHF, arterial hypertension, absence of diabetes mellitus, carvedilol therapy, and the dose of carvedilol. CONCLUSIONS: The normalization in clinical status and LV size and function is not infrequently observed in patients on optimal CHF therapy. It is predicted by a set of clinical variables and favored by beta-blocker therapy. At medium term, this condition fades in a significant portion of patients.
Authors:
Giovanni Cioffi; Carlo Stefenelli; Luigi Tarantini; Cristina Opasich
Related Documents :
8880246 - Right ventricular myocardial function in arf patients. peep as a challenge for the righ...
18474816 - Independent prognostic importance of a restrictive left ventricular filling pattern aft...
10796936 - Poststress measurements of left ventricular function with gated perfusion spect: compar...
2600996 - Prognosis in hypertrophic cardiomyopathy--echocardiographic follow-up and histopatholog...
21849206 - Persistent high factor viii activity leading to increased thrombin generation - a prosp...
6839086 - The effect of oral acetohydroxamic acid on urinary saturation in stone-forming spinal c...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiac failure     Volume:  10     ISSN:  1071-9164     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-06-10     Completed Date:  2004-12-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  250-7     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Villa Bianca Hospital, Trento, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Aged
Carbazoles / therapeutic use
Female
Follow-Up Studies
Heart Failure / etiology,  physiopathology,  therapy*
Humans
Hypertension / physiopathology
Logistic Models
Male
Pacemaker, Artificial
Predictive Value of Tests
Prognosis
Propanolamines / therapeutic use
Prospective Studies
Recovery of Function / physiology
Stroke Volume / physiology
Ventricular Dysfunction, Left / physiopathology,  therapy*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 72956-09-3/carvedilol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PET abnormalities in patients with nonischemic cardiomyopathy.
Next Document:  Why is depression bad for the failing heart? A review of the mechanistic relationship between depres...